The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...

The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...

Pfizer exec Philip Dormitzer amid claims the COVID-19 vaccine announcement was delayed to avoid influencing the 2020 election ...

We view Pfizer’s dividends and share repurchase levels as reasonable. Pfizer has generally targeted close to a 50% payout in dividends as a percentage of normalized earnings, which seems about right ...

The House Judiciary Committee subpoenaed a former Pfizer executive who allegedly claimed senior members of the company ...

Federal investigators are investigating claims suggesting Pfizer delayed announcing test results of its Covid vaccine until after the 2020 presidential election, the Wall Street Journal reported ...

In November 2020, Pfizer released a statement sharing the results of its COVID-19 vaccine trials, stating that its vaccine was "95% effective against COVID-19 beginning 28 days after the first dose." ...

Pfizer's pediatric COVID-19 vaccine has an efficacy of 80.3%, according to a preliminary analysis, and meets "all immunobridging criteria required for Emergency Use Authorization," the company ...

A resident receives a dose of the Pfizer-BioNTech Covid-19 vaccine at the community health center vaccination site in the Khayelitsha township of Cape Town, South Africa, on Sept. 8.

Eight months after first authorizing the Pfizer-BioNTech COVID-19 vaccine for emergency use in the United States, the Food and Drug Administration on Monday issued full approval. Now that the ...